PROMETRIKA Announces the Availability of Pharmacovigilance Services
News Jun 05, 2015
PROMETRIKA, LLC has expanded its offerings with the addition of pharmacovigilance services for clinical trials. PROMETRIKA has selected ARISg™, a world leader in safety data collection and reporting, as our service platform.
Our drug safety and regulatory affairs professionals, and expert physicians, each with more than 23 years in the biopharmaceutical industry, provide clinical interpretation and monitoring of safety trends.
PROMETRIKA’s CEO and President, Dr. Miganush Stepanians noted, “In response to our Sponsors’ increasing needs for accurate and dependable safety monitoring and reporting, we now offer trial safety monitoring with the worldwide reporting capabilities crucial in today’s drug development environment.”
Pharmacovigilance services for all phases of clinical trials can be provided as a stand-alone service or in conjunction with clinical operations, monitoring, data management, biostatistics, and medical writing services offered by PROMETRIKA.
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE
Microbiotica Enters into Microbiome Collaboration with GenentechNews
Strategic collaboration for microbiome biomarker signatures and therapeutic discovery based on Genentech’s inflammatory bowel disease pipeline.READ MORE
Chemoradiotherapy Before Surgery Could Extend Lives of Pancreatic Cancer PatientsNews
Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery, according to unpublished clinical trial results.READ MORE
Comments | 0 ADD COMMENT
10th Annual Congress on Drug Formulation & Analytical Techniques
Sep 03 - Sep 04, 2018